Biotech Business Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Business & Finance

Molecular engineering-focused corporation reports first quarter 2005 results

LSBC's net loss on a GAAP basis was $4.1 million, or $0.13 per share, for the first quarter of 2005 compared to a net loss of $4.3 million, or $0.16 per share, for the first quarter of 2004.

Revenues for the first quarter of 2005 were $0.4 million, an increase of $0.1 million over the same period last year, and $0.1 million less than the 4th quarter of 2004. Total operating costs and expenses on a GAAP basis were $4.4 million for the first quarter of 2005, a decrease of $0.3 million, or 6%, from $4.7 million incurred in the first quarter of 2004.

...

• View Other Issues of Biotech Business Week
  
• View Other NewsRx Publications